Access Pharmaceuticals (ACCP) Reports First Quarter Results
5/16/2013 8:08:48 AM
More...
|
Access Pharmaceuticals (ACCP) to Host Fourth Quarter and Fiscal Year Investor Call on Wednesday, April 3rd at 11:00am ET
3/20/2013 7:49:23 AM
More...
|
Access Pharmaceuticals (ACCP) to Host Third Quarter Investor Call on Wednesday, November 28th
11/15/2012 10:05:53 AM
More...
|
Access Pharmaceuticals (ACCP) Announces Private Placement Financing
10/25/2012 10:35:15 AM
More...
|
Access Pharmaceuticals (ACCP) to Host Second Quarter Investor Call on Thursday, August 23, 2012
8/20/2012 10:57:16 AM
More...
|
Access Pharmaceuticals (ACCP) Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
6/28/2012 10:33:09 AM
More...
|
Access Pharmaceuticals (ACCP) to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
6/27/2012 9:28:09 AM
More...
|
Access Pharmaceuticals (ACCP) to Host Investor Call on Wednesday, May 23, 2012
5/18/2012 10:19:23 AM
More...
|
Access Pharmaceuticals (ACCP) Announces Interim Data From MuGard Phase 4 Clinical Trial in Oral Mucositis
4/17/2012 10:06:20 AM
More...
|
Access Pharmaceuticals (ACCP) Announces Interim Data From MuGard Phase 4 Clinical Trial in Oral Mucositis
4/17/2012 6:58:13 AM
More...
|
|